ClinicalTrials.gg
RecruitingNCT06839040FIRE-WOMENUpdated Feb 21, 2025

Effects of a Multidisciplinary Intervention on Fall Risk and Urinary Incontinence in Older Women

An interventional study of Group 1: ExVerbPsy and Group 2: ExVerb in Urinary Incontinence, Frailty and Balance Impairment, sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir. Recruiting at 1 site in Spain. Open to female participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-21.

Sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 56 studies in Urinary Incontinence with a site in Spain — 12 open to participants now, 13 under way, none of them phase 3. Urinary Incontinence · Spain.

Planned enrollment
21st of 46
120 · median 113
Started
2025
with 3 others
No phase
28 of 56
7 open now
Primary completion
2025-12
later than 2 of 12 live
Registered
47th of 56
by date

Among the 56 studies in Urinary Incontinence with a site in Spain, this one is the 21st largest by planned enrollment of the 46 interventional ones that give a count, is one of 4 that started in 2025, is one of 28 with no phase, reaches primary completion later than 2 of the 12 other live ones, and was the 47th registered.

Urinary Incontinence

988 studies on the registry are indexed under Urinary Incontinence; 184 are open to participants now.

Browse Urinary Incontinence studies →

Open to participants now

12 of the 56 studies in Urinary Incontinence with a site in Spain are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 113 Urinary Incontinence studies recruiting now, 63 (56%) set no upper age limit and 35 (31%) stop at 75 or younger; 15 take children under 18; 28 take healthy volunteers.

This study: 60 Years to 80 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Urinary Incontinence with a site in Spain, or all of them as a file.
02

Study summary

This will be a quantitative, quasi-experimental, and longitudinal study spanning 18 weeks of intervention, followed by a 24-week follow-up, scheduled to begin in January 2025.

The primary objective of this study is to evaluate the effects of a multidisciplinary intervention comprising physiotherapy, physical exercise, and psychoeducation on fall risk and urinary incontinence in non-institutionalized older adult women aged 60 to 80 years. Participants will be randomly assigned to one of four groups:

  1. A multicomponent exercise group with verbal instructions for pelvic floor exercises.
  2. A multicomponent exercise group with verbal instructions for pelvic floor exercises and psychoeducation.
  3. A multicomponent exercise group without verbal instructions for pelvic floor exercises.
  4. A control group.

Multicomponent exercise sessions will be conducted twice a week, while the psychoeducation group will participate in five group therapy sessions throughout the program. The variables to be analyzed include balance, strength, power, pelvic floor function, quality of life, and self-esteem.

Read the detailed description

The aging process can lead to the development of major geriatric syndromes, such as falls and urinary incontinence. Although there are studies demonstrating the effectiveness of physical exercise and education in addressing these conditions, there is currently very limited evidence on the combined effects of both therapies on these syndromes.

The primary objective of this study is to evaluate the effects of a multidisciplinary intervention consisting of physiotherapy, physical exercise, and psychoeducation on the risk of falls and urinary incontinence in older adult women.

Methods: This will be a quantitative, quasi-experimental, and longitudinal study with 18 weeks of intervention and a 24-week follow-up period. The study is scheduled to begin in January 2025. The sample will consist of non-institutionalized older adult women aged between 60 and 80 years, who will be randomly assigned to one of four groups:

  1. A multicomponent exercise group with verbal instructions targeting the pelvic floor.
  2. A multicomponent exercise group with verbal instructions targeting the pelvic floor and psychoeducation.
  3. A multicomponent exercise group without verbal instructions targeting the pelvic floor.
  4. A control group.

Multicomponent exercise sessions will be conducted twice a week and will include exercises focused on balance, strength/power using elastic bands, aerobic capacity, and coordination. The verbal instructions for the pelvic floor will involve performing fast and slow contractions during the general exercises. Participants in the psychoeducation group will attend five group therapy sessions throughout the program.

The study will analyze variables related to balance (Timed Up and Go test, functional reach test, and posturography), lower limb strength/power (isometric strength tests and jump performance), and pelvic floor function (using the PERFECT scale and electromyography). Additionally, physical, psychological, and social well-being variables will be assessed using instruments such as the SF-36, ICIQ-SF, and Rosenberg self-esteem scale.

Results/Conclusion: It is anticipated that differences will emerge between the study groups, with the trimodal intervention group (multicomponent exercise + specific verbal instructions for the pelvic floor + psychoeducation) showing greater improvements in certain parameters.

03

Conditions studied

  • Urinary Incontinence
  • Frailty
  • Balance Impairment

Keywords

  • older women
  • pelvic floor
  • balance
  • multicomponent exercise
  • urinary incontinence
  • phsychoeducation
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Woman, aged between 60 and 80 years.
  • Not having done physical exercise in the last 3 months.
  • Present UI (SUI, UUI or MUI) after clinical diagnosis.
  • Score greater than 90 on the Barthel Scale.
  • Not present pathologies or functional alterations that limit the practice of physical exercise.
  • Not present severe cognitive alterations or mild cognitive deficit (Global Deterioration Scale less than or equal to 2 or greater than or equal to 25 points).
  • Maintain walking without support products.
  • Carry out 80% of the total sessions

Exclusion criteria

Exclusion Criteria:

  • Intake of medication that could affect the performance of the exercise or alter the variables studied.
  • Present grade II-IV uterine prolapses.
  • Clinical disease or syndrome (chronic or acute cardiovascular, neurological, respiratory or musculoskeletal disorders) that may interfere with the performance of the intervention and evaluation.
  • Present visual and/or auditory alterations that make it difficult to carry out the intervention and evaluation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Multi-component exercise group with verbal instructions for the pelvic floor and psychoeducation

    A multidisciplinary intervention will be carried out, consisting of an initial phase of individual physiotherapy based on specific active muscle training of the pelvic floor (EMSP). This will be followed by a group-based multi-component physical exercise program with instructions on pelvic floor contraction during the exercises, and psychoeducation sessions to help cope with the fear of increased likelihood of falls and urinary incontinence as a result of aging.

    Other: Group 1: ExVerbPsy

  • Active comparator
    Multi-component exercise group with verbal instructions for the pelvic floor

    The same procedure as experimental group 1 (exercise + verbal instructions + psychoeducation) will be performed except for the psychoeducation sessions.

    Other: Group 2: ExVerb

  • Active comparator
    Multicomponent exercise group without verbal instructions for the pelvic floor

    The same procedure as experimental group 1 (exercise + verbal instructions + psychoeducation) will be performed but without verbal instructions and psychoeducation sessions.

    Other: Group 3: Ex

  • No intervention
    Control group

    They will receive information sessions on the prevention of geriatric syndromes and will be asked to maintain their normal activity level. At the end of the interventions, this group will have the option of receiving the appropriate intervention that was not carried out in the initial process.

Interventions

  • OtherGroup 1: ExVerbPsy

    A multidisciplinary intervention will be carried out, consisting of an initial phase of individual physiotherapy based on specific active muscle training of the pelvic floor (EMSP). This will be followed by a group-based multi-component physical exercise program with instructions on pelvic floor contraction during the exercises, and psychoeducation sessions to help cope with the fear of increased likelihood of falls and urinary incontinence as a result of aging.

  • OtherGroup 2: ExVerb

    The same procedure as experimental group 1 ExVerbPsy will be performed except for the psychoeducation sessions.

  • OtherGroup 3: Ex

    The same procedure as experimental group 1 ExVerbPsy will be performed but without verbal instructions and psychoeducation sessions.

06

What researchers measure

Primary outcomes

  1. Pelvic floor

    PERFECT Scale: Power (P): with Oxford scale 0 to 5 points Endurence (E): 0 to 10 points Repetitions (R): 0 to 10 points Fast (F): 0 to 10 points

    Time frame: From enrollment to the end of treatment at 18 weeks

  2. Pelvic floor

    Intracavitary electromyography: maximum and average contraction. Outcome measure in microvolts.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  3. Pelvic floor

    Manometric perineometer: maximum contraction. Outcome measure in millimeters of mercury.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  4. Abdominal muscle tone

    Abdominal ultrasound of rectus and transverse abdominis: in relaxation and activation with diaphragmatic breathing. Outcome measure in milimeters.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  5. Dynamic balance

    Timed Up and Go: the time it takes for the person to get up from a chair, walk 3 meters, turn on a cone, return to the chair and sit down. Outcome measure in seconds. Less than 10 seconds: low risk of falling. Between 10 and 20 seconds: frailty (medium risk of falling). More than 20 seconds: high risk of falling and disability.

    Time frame: From enrollment to the end of treatment at 18 weeks

  6. Static balance

    Romberg test with feet together, semi-tandem and tandem in 10 seconds. Static one-leg standing balance test with open and closed eyes in 30 seconds. Outcome measure in seconds.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  7. Static balance

    Posturography with and without balance foam: anteroposterior and lateral axis oscillation, and degree of shift of the center of gravity (COP). Outcome measure in milimeters.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  8. Static balance

    Functional reach: distance traveled in anterior displacement with arms outstretched and feet together. Outcome measure in centimeters.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  9. Gait

    Six minutes gait with Runscribe sensors on feet and four meters gait (normal and fast speed)

    Time frame: From enrollment to the end of treatment at 18 weeks

  10. Power

    Jumps (CMJ and ABK), leg extension and squad. Outcome measure in wats.

    Time frame: From enrollment to the end of treatment at 18 weeks

  11. Power and strenght

    Five sit to stand, thirty sit to stand and arm curl. Outcome measure in number of repetitions in 30 seconds.

    Time frame: From enrollment to the end of treatment at 18 weeks

  12. Strenght and endurance

    Isometries of leg extension, hip extension, hip abduction, hip adduction, spine extension and hand grip. Outcome measure in newtons.

    Time frame: From enrollment to the end of treatment at 18 weeks

  13. Health impact and quality of life

    International Consultation on Incontinence Questionnaire (ICIQ-SF): 0 to 21 points from urinary incontinence impact. Outcome measure in units on a scale.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  14. Psychological and social well-being

    Falls efficacy scale: 16 to 64 points from least to most worry about falling. Outcome measure in units on a scale.

    Time frame: From enrollment to the end of treatment at 18 weeks.

Secondary outcomes

  1. Quality of live

    Quality of live with questionnaire Short Form (SF36): this questionnaire evalues in 36 questions the physical function, physical role, body pain, general health, vitality, social function, emotional role, and mental health. 0 to 100 points. Outcome measure in units on a scale.

    Time frame: From enrollment to the end of treatment at 18 weeks

  2. Psychological and social well-being

    Self-esteem questionnaire of Rosenberg: 10 points low self-esteem to 40 points high self-esteem. Outcome measure in units on a scale.

    Time frame: From enrollment to the end of treatment at 18 weeks.

  3. Weight

    Kilograms and information on percentage of lean mass and fat mass.

    Time frame: From enrollment to the end of treatment at 18 weeks

  4. Height

    Stadiometer. Outcome measure in centimeters

    Time frame: From enrollment to the end of treatment at 18 weeks

07

Study locations

1 of 1 sites recruiting
  • Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir. (Doctoral School. Catholic University of ValenciaSan Vicente Mártir)
    Valencia, 46001, Spain
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Dec 2025, 9 months after the start.

Of 303 non-industry interventional studies with no phase under Urinary Incontinence, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 9 months is below that.

Counting every sponsor, half of 366 studies reached it within 15 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2025
First posted
Feb 21, 2025
StartActual
Feb 3, 2025
Primary completionEst.
Dec 2, 2025
CompletionEst.
Dec 28, 2025
Last update
Feb 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06839040
Lead sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir
Responsible party
Jorge Alarcón Jiménez (Professor, Fundación Universidad Católica de Valencia San Vicente Mártir) — Principal investigator
First posted
Feb 21, 2025
Start date
Feb 3, 2025
Primary completion
Dec 2, 2025 (estimated)
Completion
Dec 28, 2025 (estimated)
Last update
Feb 21, 2025

Study contacts

ESTHER RAMOS CASTELLANO
Contact
esther.ramos@ucv.es
+34672425826
ESTHER RAMOS CASTELLANO
principal investigator · Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir (Doctoral School. Catholic University of Valencia San Vicente Mártir)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion